(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

COVAFLU

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

COVAFLU

ST13

US500000079348133

Class

5

Filing

79348133

Registration

7191561

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

31

Latest update

02/06/2024

Trademark type

Word

Nice classes

5

Filing date

03/02/2022

Registration date

10/17/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/17/2023

Last transaction

10/17/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

GB

Examiner

REID, MONICA R

Law office

N80

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Clinova Limited

Representatives

Joseph V. Myers III SEYFARTH SHAW LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Chemical test reagents for medical usereagents for use in viral antigen detectionantibody detection and Polymerase Chain Reaction; medical diagnostic test strips for salivamucusbloodurinenasal swabnasopharyngeal swab and oropharyngeal swab analysis; diagnostic testing materials for medical usemedical diagnostic test media in the form of strips for detecting and measuring viral antigens and antibodies; reagents for use in medical testing; chemical preparations for testing for medical purposescell lysis solutionsRNA extraction solutionsvirus inactivating solutions in the nature of detergent buffers; reagents for use in diagnostic testsdiagnostic reagents for medical use in particular PCR polymerasePCR primerslabelled nucleotides for PCR in addition to the aforementioned cell lysis solutionsRNA extraction solutionsvirus inactivating solutionslabelled antibodies; tests comprised of reagents for medical purposes; Testing kits comprised of medical diagnostic reagents and assays for testing the presence of antibodies and viruses; sanitizing preparations for household use; antimicrobial skin sanitizer gels; chemical preparations for sanitary use; disinfectants for sanitary use; sanitary preparations and articlessanitary preparations for medical use; hand-sanitizing preparations; disinfecting handwash; anti-microbial handwashes and hand lotions; pharmaceuticalsmedical and veterinary preparations for the treatment and prevention of airborne viral diseases; sanitary preparations for medical purposes; dietetic food and substances adapted for medical and veterinary usefood for babies; dietary supplements for human beings and animals; medical plastersmaterials for dressings in the nature of gauze for dressings; material for stopping teethdental wax; disinfectants; preparations for destroying vermin; fungicidesherbicides; testing kits for medical purposesdiagnostic test kits comprised of medical diagnostic reagents to diagnose influenza and respiratory infections

Publications

History of USPTO decisions and trademark events.

31 publications found

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

02/06/2024

FICS

FINAL DISPOSITION NOTICE SENT TO IB

01/18/2024

FIMP

FINAL DISPOSITION PROCESSED

01/18/2024

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

01/17/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

10/17/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

10/17/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/01/2023

PUBO

PUBLISHED FOR OPPOSITION

08/01/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/12/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/22/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/26/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/25/2023

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

05/25/2023

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

04/18/2023

GNFR

FINAL REFUSAL E-MAILED

04/18/2023

CNFR

FINAL REFUSAL WRITTEN

04/18/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/07/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/07/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/07/2023

RFNT

REFUSAL PROCESSED BY IB

03/06/2023

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

02/09/2023

RFRR

REFUSAL PROCESSED BY MPU

02/09/2023

ATRV

ATTORNEY REVIEW COMPLETED

01/10/2023

CREV

CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED

01/09/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

12/15/2022

CNRT

NON-FINAL ACTION WRITTEN

12/14/2022

DOCK

ASSIGNED TO EXAMINER

12/14/2022

CRCV

CORRECTION TRANSACTION RECEIVED FROM IB

11/06/2022

MAFR

APPLICATION FILING RECEIPT MAILED

08/30/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/26/2022

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

08/25/2022

Continuous trademark protection

Get notified about every new filing that threatens COVAFLU or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.